Cirrhosis, Liver Diseases
Conditions
Keywords
Chronic Liver Disease
Brief summary
This study looks at the iontophoresis of urotensin II in chronic liver disease patients.
Interventions
DRUGurotensin II
Sponsors
Bayside Health
Study design
Observational model
DEFINED_POPULATION
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes
Inclusion criteria
* Cirrhosis
Countries
Australia
Contacts
Primary ContactWilliam W Kemp, MBBS, FRACP
Outcome results
None listed